MALLINCKRODT PLC (MNK) Stock Price & Overview
NYSEARCA:MNK • IE000O3L0NQ3
Current stock price
The current stock price of MNK is 0.3402 USD. Today MNK is down by -14.97%. In the past month the price decreased by -68.5%.
MNK Key Statistics
- Market Cap
- 4.481M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
MNK Stock Performance
MNK Stock Chart
MNK Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to MNK.
MNK Earnings
MNK Forecast & Estimates
MNK Groups
Sector & Classification
MNK Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
MNK Ownership
MNK Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 25.12 | 846.194B | ||
| JNJ | JOHNSON & JOHNSON | 20.64 | 576.236B | ||
| MRK | MERCK & CO. INC. | 23.12 | 294.041B | ||
| PFE | PFIZER INC | 9.06 | 156.828B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 9.24 | 121.027B | ||
| ZTS | ZOETIS INC | 16.01 | 49.233B | ||
| RPRX | ROYALTY PHARMA PLC- CL A | 8.97 | 27.078B | ||
| VTRS | VIATRIS INC | 5.2 | 15.394B | ||
| ELAN | ELANCO ANIMAL HEALTH INC | 21.99 | 12.22B | ||
| AXSM | AXSOME THERAPEUTICS INC | N/A | 8.402B | ||
| TERN | TERNS PHARMACEUTICALS INC | N/A | 5.647B | ||
| BLTE | BELITE BIO INC - ADR | N/A | 5.596B | ||
| CORT | CORCEPT THERAPEUTICS INC | 45.51 | 4.098B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the NYSE Arca Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About MNK
Company Profile
Mallinckrodt Plc engages in the development, manufacture, market, adn distribution of both branded and generic specialty pharmaceutical products and medical imaging agents. The firm operates in two reportable segments: Specialty Brands and Specialty Generics. The Specialty Brands includes specialty pharmaceutical brands. The Specialty Generics includes niche specialty generic drugs and active pharmaceutical ingredients. Its Specialty Generics segment is focused on providing its customers with specialty generic drugs and active pharmaceutical ingredients (APIs). The firm focuses on various therapeutic areas, such as autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics, cultured skin substitutes and gastrointestinal products. Its product portfolio includes Acthar Gel, INOmax, Therakos photopheresis, StrataGraft, Terlivaz, and Amitiza.
Company Info
IPO: 2013-07-15
MALLINCKRODT PLC
College Business & Technology Park, Cruiserath,, Blanchardstown
DUBLIN D15 IE
CEO: Mark C. Trudeau
Employees: 2700
MALLINCKRODT PLC / MNK FAQ
Can you describe the business of MALLINCKRODT PLC?
Mallinckrodt Plc engages in the development, manufacture, market, adn distribution of both branded and generic specialty pharmaceutical products and medical imaging agents. The firm operates in two reportable segments: Specialty Brands and Specialty Generics. The Specialty Brands includes specialty pharmaceutical brands. The Specialty Generics includes niche specialty generic drugs and active pharmaceutical ingredients. Its Specialty Generics segment is focused on providing its customers with specialty generic drugs and active pharmaceutical ingredients (APIs). The firm focuses on various therapeutic areas, such as autoimmune and rare diseases in specialty areas like neurology, rheumatology, hepatology, nephrology, pulmonology, ophthalmology, and oncology; immunotherapy and neonatal respiratory critical care therapies; analgesics, cultured skin substitutes and gastrointestinal products. Its product portfolio includes Acthar Gel, INOmax, Therakos photopheresis, StrataGraft, Terlivaz, and Amitiza.
Can you provide the latest stock price for MALLINCKRODT PLC?
The current stock price of MNK is 0.3402 USD. The price decreased by -14.97% in the last trading session.
What is the dividend status of MALLINCKRODT PLC?
MNK does not pay a dividend.
What is the ChartMill technical and fundamental rating of MNK stock?
MNK has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 0 out of 10.
Where is MALLINCKRODT PLC (MNK) stock traded?
MNK stock is listed on the NYSE Arca exchange.
What sector and industry does MALLINCKRODT PLC belong to?
MALLINCKRODT PLC (MNK) operates in the Health Care sector and the Pharmaceuticals industry.
What is the ownership structure of MALLINCKRODT PLC (MNK)?
You can find the ownership structure of MALLINCKRODT PLC (MNK) on the Ownership tab.